Skip to main content
Caplight Logo









LiberEat

LiberEat

Private
AberdeenEnterprise Softwarehttps://libereat.com/

Last Round

Grant

Oct 1, 2022

Total Funding Raised

$420,000

Company Overview

LiberEat is a health-tech company that provides an AI-powered allergen detection platform for food businesses to identify and prevent safety-critical ingredient errors.

Sector

Enterprise Software

Verticals

Compliance & Risk, Vertical SaaS, Retail Technology, Data Integration, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

allergen managementfood safety softwareallergen softwareallergen detectionfood safety techfood compliancefoodtechingredient managementmenu managementfood labelingmenu complianceAPISaaSNatasha's Law compliancefood safety automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LiberEat Comparables

Compare LiberEat with similar companies based on industry and business-model similarity.

LiberEat comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Erudus Limited
84%
TrustDish
84%
Nutritics
81%

LiberEat Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 1, 2022
SeedMay 25, 2021
AcceleratorFeb 1, 2020
GrantFeb 1, 2020

Key People

Founding team and executive leadership

Barry Leaper

Founder & CEO

Founding Team

LiberEat Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2025

    Monthly visitors grew 77% MoM.

  • Oct 1, 2022

    $240K grant received from Innovate UK.

LiberEat Filings

Explore SEC and related filing metadata, where available.

LiberEat filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about LiberEat's valuation, stock price, and market status.

Is LiberEat a public or private company?

LiberEat is a private company.

What is the current stock price of LiberEat?

LiberEat is a private company with no public stock price. Caplight tracks LiberEat's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is LiberEat worth (valuation)?

Valuation information for LiberEat is not publicly available.

Can I buy LiberEat stock?

LiberEat shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was LiberEat's last funding round?

LiberEat's most recent funding round was Grant on October 1, 2022.

Who are the main investors in LiberEat?

Key investors in LiberEat include Innovate UK.

Will LiberEat IPO soon?

No public IPO plans have been announced for LiberEat.

How can I track LiberEat secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor LiberEat's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAberdeen
Employee Range9
Year Founded2016
Last FundingOct 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?